Observational study to estimate the rates of outcomes in patients undergoing percutaneous coronary intervention (PCI) with drug eluting stent (DES) implantation who take statins - OPTIMA

Exclusion Criteria

• - Subjects who are unwilling or unable to provide informed consent.
• - Presence of ACS during the current hospitalization
• - Severe CHF (NYHA III/IV) or LVEF<40 %
• - Stroke within 6 months before PCI
• - Acute or chronic inflammatory disease
• - Anti-inflammatory medications intake, with the exception of aspirin
• - Severe liver or muscle disease
• - Severe kidney disease / renal failure with creatinine > 3 mg/dl
• - History of oncologic disease
• - Conceivable impossibility to come in touch with the patient or his family at 1-year after the intervention